Pharma Pulse 9/30/24: RWD Regulatory Concerns, OpenAI’s Latest Drama & more

Regulatory Concerns Associated With Utilizing RWD

In this video interview with ACT editor Andy Studna, Rich Gliklich, founder of OM1 highlights existing guidances on real-world data and where there is room for even more oversight.

Black Women With Breast Cancer Have Higher Risk of Death Compared With White Women

Study results showed that Black women with breast cancer were more likely to die across all subtypes, with the disparity varying from 17% to 50% depending on subtype.

‘We Are Not a Normal Company’: OpenAI’s Latest Drama

More high-level departures caught some at the high-flying A.I. start-up off guard, as the company seeks to raise billions to fund its operations and ambitious goals.

Next Health Announces Proactive Healthcare and Longevity Centers Coming Soon to Tampa and St. Petersburg

Next Health, the world's most advanced brand of proactive healthcare centers, is bringing two health optimization and longevity centers to Tampa and St. Petersburg through an area development agreement. This announcement follows Next Health’s 11-unit expansion in the Sunshine State across the cities of Miami, Ft. Lauderdale, Palm Beach, and Boca Raton.

IQVIA United States on LinkedIn

In today's fast-paced market, agility is the key to staying ahead. Discover how to optimize ROI and enhance the customer experience with the right strategy, insights, and resource model. Check out this insightful article by #IQVIA’s Kirk Harmon and Javier "Jave" Castillo on Pharmaceutical Executive -https://bit.ly/4eBWAwZ

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs